The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
High-throughput functional genomics using CRISPR-Cas9
Open accessAbstract
Forward genetic screens are powerful tools for the discovery and functional annotation of genetic elements. Recently, the RNA-guided CRISPR (clustered regularly interspaced short palindromic repeat)-associated Cas9 nuclease has been combined with genome-scale guide RNA libraries for unbiased, phenotypic screening. In this Review, we describe recent advances using Cas9 for genome-scale screens, including knockout approaches that inactivate genomic loci and strategies that modulate transcriptional activity. We discuss practical aspects of screen design, provide comparisons with RNA interference (RNAi) screening, and outline future applications and challenges.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the deficiencies of RNAi-based methods in the areas of reagent fidelity and scalability make it difficult to use this approach to accurately map drug target interactions across a large matrix of cell lines and drug treatments”
From A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor Evolution (2017) · cites this paper as Shalem et al., 2015
Experimental — accuracy not yet measuredIn the citing paper
“This has limited pooled screens largely to vetting genes for their potential impact on cell fitness”
From Protein Barcodes Enable High-Dimensional Single-Cell CRISPR Screens (2018) · cites this paper as Shalem et al., 2015
In the citing paper
“So far three distinct bacterial CRISPR systems have been identified; Type I, II and III, and it is the Type II system that has mainly been adapted for use in artificial gene regulation and genome editing (Kim and Kim 2014; Shalem, Sanjana and Zhang 2015).”
From Candida glabrata : new tools and technologies—expanding the toolkit (2015) · cites this paper as Shalem, Sanjana and Zhang 2015
In the citing paper
“The most commonly used CRISPR Type II system consists of a gRNA and an endonuclease, the CRISPR-associated (Cas) nuclease, Cas9, which cleaves the targeted chromosomal DNA in a site-specific manner triggering endogenous DNA repair systems resulting in genome modification (for an in-depth review, see Doudna and Charpentier 2014; Kim and Kim 2014; Shalem, Sanjana and Zhang 2015).”
From Candida glabrata : new tools and technologies—expanding the toolkit (2015) · cites this paper as Shalem, Sanjana and Zhang 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Self-citationRNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
MicroRNAs: small RNAs with a big role in gene regulation
He, L., & Hannon, G. J. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1379 · Cited by 7,118
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762
Self-citationImproved vectors and genome-wide libraries for CRISPR screening
Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239
Self-citationGenome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
Self-citationRepurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016
Flagged first, then by citations
Cited by
Sorted by citations
Items 601–700 of 1,000
Dayanc, B., Eris, S., Gulfirat, N. E., Özden-Yılmaz, G., Çakıroğlu, E., Deniz, O. S. C., Karakülah, G., Erkek, S., & Şentürk, Ş. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07711-z · Cited by 18
Optimization of CRISPR–Cas system for clinical cancer therapy
Meng, X. L., Wu, T., Lou, Q., Niu, K., Jiang, L., Xiao, Q., Xu, T., & Zhang, L. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10474 · Cited by 18
Advances in breast cancer research using CRISPR/Cas9 system
Eskandari, F., Aali, M., Hadisadegh, S. N., & Azadeh, M. (2024) · Nano Select · doi:10.1002/nano.202400015 · Cited by 18
Molecular phenotyping of infection-associated small non-coding RNAs
Barquist, L., Westermann, A. J., & Vogel, J. (2016) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2016.0081 · Cited by 18
To Crispr And Beyond: The Evolution Of Genome Editing In Stem Cells
Chen, K.-Y. M., & Knoepfler, P. S. (2016) · Regenerative Medicine · doi:10.2217/rme-2016-0107 · Cited by 18
Pluripotent Stem Cell-Derived Human Tissue: Platforms to Evaluate Drug Metabolism and Safety
Meseguer-Ripolles, J., Khetani, S. R., Blanco, J. G., Iredale, M., & Hay, D. C. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0171-8 · Cited by 19
Recent advances in lineage differentiation from stem cells: hurdles and opportunities?
Terryn, J., Tricot, T., Gajjar, M. K., & Verfaillie, C. M. (2018) · F1000Research · doi:10.12688/f1000research.12596.1 · Cited by 19
CRISPR-based methods for high-throughput annotation of regulatory DNA
Klann, T. S., Black, J. B., & Gersbach, C. A. (2018) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2018.02.004 · Cited by 19
Multiparametric Assays for Accelerating Early Drug Discovery
Herholt, A., Galinski, S., Geyer, P. E., Rossner, M. J., & Wehr, M. C. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.02.005 · Cited by 18
Wu, Y., Zhou, L., Wang, Z., Wang, X., Zhang, R., Zheng, L., & Kang, T. (2020) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2020.0162 · Cited by 19
Qi, M., Zhang, B., Jiang, L., Xu, S., Dong, C., Du, Y., Zhou, Z. M., Huang, L., Xu, Z., & Lian, J. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.613771 · Cited by 18
Discovering antiviral restriction factors and pathways using genetic screens
Jones, C. E., Tan, W. S., Grey, F. E., & Hughes, D. J. (2021) · Journal of General Virology · doi:10.1099/jgv.0.001603 · Cited by 20
Ford, K. M., Panwala, R., Chen, D.-H., Portell, A. J., Palmer, N. D., & Mali, P. (2021) · Cell Systems · doi:10.1016/j.cels.2021.05.002 · Cited by 22
Principles of brain aging: Status and challenges of modeling human molecular changes in mice
Kluever, V., & Fornasiero, E. F. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101465 · Cited by 18
Modifier pathways in polyglutamine (PolyQ) diseases: from genetic screens to drug targets
Costa, M. D., & Maciel, P. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04280-8 · Cited by 19
Practical Considerations for Using Pooled Lentiviral CRISPR Libraries
McDade, J. R., Waxmonsky, N. C., Swanson, L. E., & Fan, M. (2016) · Current Protocols in Molecular Biology · doi:10.1002/cpmb.8 · Cited by 18
Peter, J., Toppeta, F., Trubert, A., Danhof, S., Hudecek, M., & Däullary, T. (2025) · Oncology Research and Treatment · doi:10.1159/000543806 · Cited by 19
Engineering novel CRISPRi repressors for highly efficient mammalian gene regulation
Kristof, A., Karunakaran, K., Allen, C., Mizote, P., Briggs, S., Jian, Z., Nash, P., & Blazeck, J. (2025) · Genome biology · doi:10.1186/s13059-025-03640-4 · Cited by 17
AARS1 and AARS2: From Protein Synthesis to Lactylation-Driven Oncogenesis
Gao, L., Guo, J., & Jia, R. (2025) · Biomolecules · doi:10.3390/biom15091323 · Cited by 18
Cho, H.-J., Lee, W. S., Jeong, J., & Lee, J.-S. (2022) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2022.109428 · Cited by 21
The CRISPR revolution and its impact on cancer research
Kannan, R., & Ventura, A. (2015) · Swiss Medical Weekly · doi:10.4414/smw.2015.14230 · Cited by 17
Reduced IL-37 Production Increases Spontaneous Chemokine Expressions in Colon Epithelial Cells
Günaltay, S., Ghiboub, M., Hultgren, O., & Hörnquist, E. H. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4422-9 · Cited by 17
Computational Prediction of Protein Complexes from Protein Interaction Networks
Srihari, S., Yong, C. H., & Wong, L. (2017) · doi:10.1145/3064650 · Cited by 17
CRISPR/Cas9-based gene targeting using synthetic guide RNAs enables robust cell biological analyses
Su, K.-C., Tsang, M., Emans, N., & Cheeseman, I. M. (2018) · Molecular Biology of the Cell · doi:10.1091/mbc.e18-04-0214 · Cited by 17
Shortt, K., Heruth, D. P., Zhang, N., Wu, W., Singh, S., Li, D., Zhang, L. Q., Wyckoff, G. J., Qi, L. S., Friesen, C. A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-37940-6 · Cited by 17
Tracing cellular heterogeneity in pooled genetic screens via multi-level barcoding
Boettcher, M., Covarrubias, S., Biton, A., Blau, J. A., Wang, H., Zaitlen, N., & McManus, M. T. (2019) · BMC Genomics · doi:10.1186/s12864-019-5480-0 · Cited by 17
A simple and efficient cloning system for CRISPR/Cas9-mediated genome editing in rice
Liu, X., Zhou, X., Li, K., Wang, D., Ding, Y., Liu, X., Luo, J., & Fang, C. (2020) · PeerJ · doi:10.7717/peerj.8491 · Cited by 17
Web-Based Base Editing Toolkits: BE-Designer and BE-Analyzer
Hwang, G., & Bae, S. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0822-7_7 · Cited by 17
Application of CRISPR/Cas system for genome editing in cotton
Fiaz, S., Khan, S. A., Younas, A., Shahzad, K., Ali, H., Noor, M. A., Ashraf, U., & Nadeem, F. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821910-2.00010-2 · Cited by 17
CRISPRi/a Screening with Human iPSCs
Nishiga, M., Qi, L. S., & Wu, J. C. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1484-6_23 · Cited by 17
Efficient genome editing in Claviceps purpurea using a CRISPR/Cas9 ribonucleoprotein method
Yu, L., Xiao, M., Zhu, Z., Wang, Y., Zhou, Z., Wang, P., & Zou, G. (2022) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2022.02.002 · Cited by 17
Deciphering Combinatorial Genetics
Wong, A. S. L., Choi, G. C. G., & Lu, T. K. (2016) · Annual Review of Genetics · doi:10.1146/annurev-genet-120215-034902 · Cited by 17
Zhang, C., & Lü, L. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7104-6_17 · Cited by 17
Synthetic Biology-Based Approaches to Investigate Host–Pathogen Interactions
Banerjee, R. (2025) · SynBio · doi:10.3390/synbio3010004 · Cited by 16
PAM-adjacent DNA flexibility tunes CRISPR-Cas12a off-target binding
Allen, A., Cooper, B. H., Singh, J. K., Rohs, R., & Qin, P. Z. (2025) · Scientific Reports · doi:10.1038/s41598-025-87565-9 · Cited by 17
Neuromuscular disorders: finding the missing genetic diagnoses
Koczwara, K. E., Lake, N. J., DeSimone, A. M., & Lek, M. (2022) · Trends in Genetics · doi:10.1016/j.tig.2022.07.001 · Cited by 16
ZBTB7A promotes virus-host homeostasis during human coronavirus 229E infection
Zhu, X., Trimarco, J. D., Williams, C. A., Barrera, A., Reddy, T. E., & Heaton, N. S. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111540 · Cited by 16
BESST: a novel LncRNA knockout strategy with less genome perturbance
Zhang, S., Chen, Y., Dong, K., Zhao, Y., Wang, Y., Wang, S., Qu, C., Xu, N., Xie, W., Zeng, C., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad197 · Cited by 16
Cui, R., Luo, Z., Zhang, X., Yu, X., Yuan, G., Li, X., Xie, F., & Jiang, O. (2025) · Vaccines · doi:10.3390/vaccines13030292 · Cited by 16
Sansbury, B. M., Wagner, A. M., Nitzan, E., Tarcic, G., & Kmiec, E. B. (2018) · The CRISPR Journal · doi:10.1089/crispr.2018.0006 · Cited by 16
CRISPR-mediated transcriptional activation with synthetic guide RNA
Strezoska, Ž., Dickerson, S. M., Maksimova, E. M., Chou, E. T., Gross, M. M., Hemphill, K., Hardcastle, T., Perkett, M. R., Stombaugh, J., Miller, G. W., et al. (2020) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2020.05.005 · Cited by 16
CRISPR/Cas9 Targeted Mutagenesis for Functional Genetics in Maize
Hunter, C. T. (2021) · Plants · doi:10.3390/plants10040723 · Cited by 16
Wang, Q., Li, J., Zhu, J., Mao, J., Duan, C., Liang, X., Zhu, L., Zhu, M., Zhang, Z., Lin, F., et al. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.882 · Cited by 17
Systematic elucidation of genetic mechanisms underlying cholesterol uptake
Hamilton, M. C., Fife, J. D., Akinci, E., Yu, T., Khowpinitchai, B., Cha, M., Barkal, S., Thi, T. T., Yeo, G. H. T., Ramos Barroso, J. P., et al. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100304 · Cited by 16
Progress and Application of CRISPR/Cas Technology in Biological and Biomedical Investigation
Lin, J., Zhou, Y., Liu, J., Chen, J., Chen, W., Zhao, S., Wu, Z., & Wu, N. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26198 · Cited by 16
Rscreenorm: normalization of CRISPR and siRNA screen data for more reproducible hit selection
Bachas, C., Hodzic, J., van der Mijn, J. C., Stoepker, C., Verheul, H. M. W., Wolthuis, R. M. F., Felley‐Bosco, E., van Wieringen, W. N., van Beusechem, V. W., Brakenhoff, R. H., et al. (2018) · BMC Bioinformatics · doi:10.1186/s12859-018-2306-z · Cited by 16
CRISPR Guide RNA Cloning for Mammalian Systems
Nageshwaran, S., Chavez, A., Yeo, N. C., Guo, X., Lance‐Byrne, A., Tung, A., Collins, J. J., & Church, G. M. (2018) · Journal of Visualized Experiments · doi:10.3791/57998 · Cited by 16
Dowaidar, M. (2021) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/3nwzd · Cited by 22
High-Throughput CRISPR Screening in Hematological Neoplasms
Ancos-Pintado, R., Bragado-García, I., Morales, M. L., García-Vicente, R., Arroyo-Barea, A., Rodríguez-García, A., Martínez-López, J., Linares, M., & Hernández-Sánchez, M. (2022) · Cancers · doi:10.3390/cancers14153612 · Cited by 15
Çakıroğlu, E., Eris, S., Öz, Ö., Karakülah, G., & Şentürk, Ş. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07587-z · Cited by 15
Shevade, K., Yang, Y. A., Feng, K., Mader, K., Sevi̇m, V., Parsons, J., Arora, G., Elfawy, H. A., Mace, R., Federman, S., et al. (2025) · Cell Reports Methods · doi:10.1016/j.crmeth.2025.101222 · Cited by 15
Single-cell screens identify ADAM12 as a fibroblast checkpoint impeding anti-tumor immunity
Li, J., Liu, H., Guo, Q., Zhang, Y., Li, J., Diao, T., Zheng, L., Deng, Z., Yang, Y., Chen, X., et al. (2026) · Cancer Cell · doi:10.1016/j.ccell.2025.12.018 · Cited by 16
CRISPR/Cas9-Mediated Customizing Strategies for Adoptive T-Cell Therapy
Park, H., Kang, Y. K., & Shim, G. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16030346 · Cited by 16
Li, Y., Zhu, L., Mao, J., Zheng, H., Hu, Z., Yang, S., Mao, T., Zhou, T., Cao, P., Wu, H., et al. (2024) · MedComm · doi:10.1002/mco2.483 · Cited by 15
Peng, G., Liu, T., Qi, X., Wang, Y., Ren, J., Peng, J., Du, X., Hu, S., Wu, S., Zhao, Y., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012104 · Cited by 15
Aghaali, Z., & Naghavi, M. R. (2024) · BMC Plant Biology · doi:10.1186/s12870-024-05412-x · Cited by 15
Discovery of therapeutic targets in cancer using chromatin accessibility and transcriptomic data
Forbes, A. N., Xu, D., Cohen, S. M., Pancholi, P., & Khurana, E. (2024) · Cell Systems · doi:10.1016/j.cels.2024.08.004 · Cited by 16
Progress With Nonhuman Animal Models of Addiction
Crabbe, J. C. (2016) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2016.77.696 · Cited by 15
Wu, C., Zhang, S., Lin, L., Gao, S., Fu, K., Liu, X.-D., Liu, Y., Zhou, L.-J., & Zhou, P. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4472 · Cited by 15
Mouse models in the era of large human tumour sequencing studies
de Ruiter, J. R., Wessels, L. F. A., & Jonkers, J. (2018) · Open Biology · doi:10.1098/rsob.180080 · Cited by 16
A combination of transcription factors mediates inducible interchromosomal contacts
Kim, S., Dunham, M. J., & Shendure, J. (2019) · eLife · doi:10.7554/elife.42499 · Cited by 15
McNamar, R., Abu-Adas, Z., Rothblum, K. N., Knutson, B. A., & Rothblum, L. I. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.009902 · Cited by 15
Baddal, B. (2019) · Pathogens and Disease · doi:10.1093/femspd/ftz060 · Cited by 15
Role of Modern Technologies in Tissue Engineering
Ali, Q., Malik, S., Malik, A., Hafeez, M. N., & Salman, S. (2020) · Archives of Neuroscience · doi:10.5812/ans.90394 · Cited by 15
A guideline and challenges toward the minimization of bacterial and eukaryotic genomes
Kurasawa, H., Ohno, T., Arai, R., & Aizawa, Y. (2020) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2020.10.012 · Cited by 15
A CRISPR knockout screen reveals new regulators of canonical Wnt signaling
Evron, T., Caspi, M., Kazelnik, M., Shor-Nareznoy, Y., Armoza-Eilat, S., Kariv, R., Manber, Z., Elkon, R., Sklan, E. H., & Rosin‐Arbesfeld, R. (2021) · Oncogenesis · doi:10.1038/s41389-021-00354-7 · Cited by 15
Death receptor-based enrichment of Cas9-expressing cells
Liesche, C., Venkatraman, L., Aschenbrenner, S., Große, S., Grimm, D., Eils, R., & Beaudouin, J. (2016) · BMC Biotechnology · doi:10.1186/s12896-016-0250-4 · Cited by 15
Su, D., Wang, M., Ye, C., Fang, J., Duan, Y., Zhang, Z., Hua, Q., Shi, C., Zhang, L., Zhang, R., et al. (2017) · Scientific Reports · doi:10.1038/srep44476 · Cited by 15
Modeling genotypes in their microenvironment to predict single- and multi-cellular behavior
Voukantsis, D., Kahn, K., Hadley, M., Wilson, R., & Buffa, F. M. (2019) · GigaScience · doi:10.1093/gigascience/giz010 · Cited by 16
Urnov, F. D. (2016) · Nature · doi:10.1038/529468a · Cited by 14
Nanoparticle-based non-viral CRISPR delivery for enhanced immunotherapy
Shin, H., & Kim, J. (2022) · Chemical Communications · doi:10.1039/d1cc05999h · Cited by 14
Liu, Q. H., Sun, Y., He, B., Chen, H., Wang, L., Wang, G., Zhang, K., Zhao, X., Zhang, X., Shen, D., et al. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01919-4 · Cited by 14
Fabrication of thin‐layer matrigel‐based constructs for three‐dimensional cell culture
Ko, K. R., Tsai, M., & Frampton, J. P. (2018) · Biotechnology Progress · doi:10.1002/btpr.2733 · Cited by 14
Selection or drift: The population biology underlying transposon insertion sequencing experiments
Mahmutovic, A., Wiesch, P. A. Z., & Abel, S. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.03.021 · Cited by 14
Two SNPs in SNX2 are associated with SGIV resistance in Asian seabass
Yu, Y., Yang, Z., Sun, F., Wang, L., Lee, M., & Yue, G. H. (2021) · Aquaculture · doi:10.1016/j.aquaculture.2021.736695 · Cited by 14
Direct In Vitro Reprogramming of Astrocytes into Induced Neurons
Sharif, N., Calzolari, F., & Berninger, B. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1601-7_2 · Cited by 14
Application of CRISPR-Cas9 Gene Editing for HIV Host Factor Discovery and Validation
Cisneros, W. J., Cornish, D., & Hultquist, J. F. (2022) · Pathogens · doi:10.3390/pathogens11080891 · Cited by 16
Studying human disease using human neurons
Ahfeldt, T., Litterman, N. K., & Rubin, L. L. (2016) · Brain Research · doi:10.1016/j.brainres.2016.03.051 · Cited by 14
Leitão, A. L., Costa, M. C., & Enguita, F. J. (2016) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2016.11.009 · Cited by 14
Requirement of glycosylation machinery in TLR responses revealed by CRISPR/Cas9 screening
Sato, R., Shibata, T., Tanaka, Y., Kato, C., Yamaguchi, K., Furukawa, Y., Shimizu, E., Yamaguchi, R., Imoto, S., Miyano, S., et al. (2017) · International Immunology · doi:10.1093/intimm/dxx044 · Cited by 14
Leidy-Davis, T., Cheng, K., Goodwin, L. O., Morgan, J. L., Juan, W. C., Roca, X., Ong, S. T., & Bergstrom, D. E. (2018) · Scientific Reports · doi:10.1038/s41598-018-33408-9 · Cited by 14
Wang, F., Zhang, C., Xu, W., Yuan, S., Song, J., Li, L., Zhao, J., & Yang, J. (2020) · The Crop Journal · doi:10.1016/j.cj.2020.01.003 · Cited by 14
RELATe enables genome-scale engineering in fungal genomics
Li, Z., & Kim, K. S. (2020) · Science Advances · doi:10.1126/sciadv.abb8783 · Cited by 14
Modulating gene expression in breast cancer via DNA secondary structure and the CRISPR toolbox
Kretzmann, J. A., Irving, K. L., Smith, N. M., & Evans, C. W. (2021) · NAR Cancer · doi:10.1093/narcan/zcab048 · Cited by 14
Functional Genomics for Cancer Research: Applications In Vivo and In Vitro
O’Loughlin, T. A., & Gilbert, L. A. (2018) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030518-055742 · Cited by 14
SPARCS, a platform for genome-scale CRISPR screening for spatial cellular phenotypesPreprint
Schmacke, N. A., Mädler, S. C., Wallmann, G., Metousis, A., Bérouti, M., Harz, H., Leonhardt, H., Mann, M., & Hornung, V. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.01.542416 · Cited by 14
A genome-wide CRISPR functional survey of the human phagocytosis molecular machinery
Essletzbichler, P., Sedlyarov, V., Frommelt, F., Soulat, D., Heinz, L. X., Stefanovic, A., Neumayer, B., & Superti‐Furga, G. (2023) · Life Science Alliance · doi:10.26508/lsa.202201715 · Cited by 13
Kim, S. H., Park, J.-H., Shin, S., Shin, S., Chun, D., Kim, Y., Yoo, J., You, W., Lee, J. S., & Lee, G. M. (2024) · ACS Synthetic Biology · doi:10.1021/acssynbio.3c00646 · Cited by 14
GLiDe: a web-based genome-scale CRISPRi sgRNA design tool for prokaryotes
Xiang, T., Feng, H., Xing, X., & Zhang, C. (2025) · BMC Bioinformatics · doi:10.1186/s12859-024-06012-0 · Cited by 13
Ogbodo, J. O., Egba, S. I., Ikechukwu, G. C., Paul, P. C., Mba, J. O., Ugwu, O. P.-C., & Ezike, T. C. (2025) · Processes · doi:10.3390/pr13010154 · Cited by 13
Hu, S. W., Jeong, S., Jiang, L., Koo, H., Wang, Z., Choi, W. H., Zhu, B., Seok, H., Zhou, Y., Kim, M. G., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62562-8 · Cited by 13
CRISPR Libraries and Screening
Poirier, J. T. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.10.002 · Cited by 14
The CRISPR/Cas9 System as a Tool to Engineer Chromosomal Translocation In Vivo
Cheong, T.-C., Blasco, R. B., & Chiarle, R. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-0593-1_4 · Cited by 13
Pathway sensor-based functional genomics screening identifies modulators of neuronal activity
Herholt, A., Brankatschk, B., Kannaiyan, N. R., Papiol, S., Wichert, S. P., Wehr, M. C., & Rossner, M. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-36008-9 · Cited by 13
Integrate CRISPR/Cas9 for protein expression of HLA-B*38:68Q via precise gene editing
Yin, Y., Reed, E. F., & Zhang, Q. (2019) · Scientific Reports · doi:10.1038/s41598-019-44336-7 · Cited by 13
Li, Q. V., Rosen, B. P., & Huangfu, D. (2019) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1464 · Cited by 13
CRISPR/Cas-Mediated Abiotic Stress Tolerance in Crops
Ahmad, A., Ashraf, S., Munawar, N., Jamil, A., Ghaffar, A., & Shahbaz, M. (2021) · Springer eBooks · doi:10.1007/978-981-15-7142-8_6 · Cited by 13
Zhou, Z., Chen, G., Shen, M., Li, J., Liu, K., Liu, M., Shi, S., Yang, D., Chen, W., Chen, S., et al. (2023) · Translational Oncology · doi:10.1016/j.tranon.2023.101625 · Cited by 13
Rahmati, A., Mafi, A., Soleymani, F., Aghdam, Z. B., Masihipour, N., Ghezelbash, B., Asemi, R., Aschner, M., Vakili, O., Homayoonfal, M., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1149187 · Cited by 13
Wilson, E. L., Yu, Y., Leal, N. S., Woodward, J. A., Patikas, N., Morris, J. L., Field, S. F., Plumbly, W., Paupe, V., Chowdhury, S. R., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06568-y · Cited by 14
Metadata
- Authors
- Shalem, O., Sanjana, N. E., & Zhang, F.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Shalem, Ophir
- Zhang, Feng
- Venue
- Nature Reviews Genetics
- Published
- 2015-04-09
- Volume
- 16
- Issue
- 5
- Pages
- 299-311
- ISSN
- 1471-0056 (ISSN-L)
- 1471-0064
- PMC
- PMC4503232
- OpenAlex
- W2026592619
- Cited by
- 1,233
- References
- 130
- Citations by year
- 2026: 71 · 2025: 91 · 2024: 103 · 2023: 85 · 2022: 101 · 2021: 105 · 2020: 121 · 2019: 117 · 2018: 131 · 2017: 145 · 2016: 123 · 2015: 37
- FWCI
- 14.12
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Reviews Genetics (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
- PMC
- Funders
- Klarman Family Foundation
- Simons Center for the Social Brain, Massachusetts Institute of Technology
- National Institute of Mental Health (DP1MH100706)
- National Human Genome Research Institute (K99HG008171)
- National Institute of Neurological Disorders and Stroke (R01NS073124)
- National Center for Chronic Disease Prevention and Health Promotion (DP1‑MH100706)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- CRISPR/Cas9, genome-wide screen, guide RNA library, forward genetic screen, gene knockout, transcriptional regulation, phenotypic screening, screen design, functional genomics
- MeSH terms
- Animals, Genetic Testing, Humans, Models, Genetic, Gene Library, Genomics, RNA Interference, Mice, Gene Knockout Techniques, High-Throughput Nucleotide Sequencing, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review